Back to Trials
NCT04169542Recruiting

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

M.D. Anderson Cancer Center

Start Date

5/21/2019

Completion Date

3/31/2028

Summary

This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.

Detailed Description

PRIMARY OBJECTIVES: I. Obtain Comprehensive Score for financial Toxicity (COST) questionnaire data from the patients who are undergoing any form of mastectomy (with or without breast reconstruction). II. To determine which patients are at higher risk of financial toxicity while pursuing breast reconstruction. III. Assess if financial toxicity or distress is associated with worse BREAST-questionnaire (Q) performance as well as quality of life. IV. Identify relationships between coronavirus disease 2019 (COVID-19) related productivity losses and financial toxicity. OUTLINE: Patients complete up to 4 electronic questionnaires over 15 minutes before surgery and at 6, 12, and 24 months after surgery. After completion of study, patients will be followed up for 1 year.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history * English-speaking * Able to complete consent * Able to fill out computer survey material Exclusion Criteria: * Non-English-speaking * Those with recurrent or metastatic disease or concurrent primary cancers * Patients undergoing breast conservation therapy will also be excluded from the study

Interventions

OTHER

Questionnaire Administration

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Breast Ductal Carcinoma In SituCOVID-19 InfectionHereditary Breast CarcinomaInvasive Breast Carcinoma

Locations

MD Anderson in The Woodlands

Conroe, Texas 77384

United States

M D Anderson Cancer Center

Houston, Texas 77030

United States

MD Anderson League City

League City, Texas 77573

United States

MD Anderson in Sugar Land

Sugar Land, Texas 77478

United States